Pilant Therapeutics
selective inhibitor | Pilant Therapeutics
Company
Deck Type
IPO
Deck date
May 2020
Slide
44 of 48
Related slides by other companies
Boundless Bio
IPO
March 2024
novel selective oral inhibitor designed to disrupt and overcome limitations of prior and existing inhibitors data a sierra ase strategy | Boundless Bio
Equillium
Investor Presentation
February 2024
generation of selective inhibitors | Equillium
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io